Hannah Maynard
-
- Cancer Genomics and Diagnostics 6
-
- Pancreatic and Hepatic Oncology Research 5
- PARP inhibition in cancer therapy 2
-
- Genomics and Rare Diseases 1
-
- Cardiovascular Health and Disease Prevention 2
- Blood Pressure and Hypertension Studies 2
- Cardiac, Anesthesia and Surgical Outcomes 1
-
- Ethics in Clinical Research 1
- Co-authors
- Eileen M. O’ReillyDavid P. KelsenTalia GolanHedy L. KindlerMaeve A. LoweryZsofia K. StadlerRichard Kinh GianAmiel Segal
- Partner nations
- United StatesCanadaIsrael
In The Last Decade
Hannah Maynard
10 papers receiving 235 citations
Peers
Comparison fields: 5 of 23
- Cancer Research 139
- Oncology 197
- Pathology and Forensic Medicine 39
- Genetics 34
- Pulmonary and Respiratory Medicine 34
Countries citing papers authored by Hannah Maynard
This map shows the geographic impact of Hannah Maynard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hannah Maynard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hannah Maynard more than expected).
Fields of papers citing papers by Hannah Maynard
This network shows the impact of papers produced by Hannah Maynard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hannah Maynard. The network helps show where Hannah Maynard may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hannah Maynard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2026 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 3 | |
| 4 | 2024 | 4 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 0 | |
| 7 | 2022 | 1 | |
| 8 | 2020 | 33 | |
| 9 | 2017 | 123 | |
| 10 | 2017 | 60 | |
| 11 | 2016 | 1 | |
| 12 | 2015 | 8 | |
| 13 | 1984 | 1 |
About Hannah Maynard
Hannah Maynard is a scholar working on Cancer Research, Oncology and Cardiology and Cardiovascular Medicine, having authored 13 papers that have together received 235 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (6 papers), Pancreatic and Hepatic Oncology Research (5 papers), PARP inhibition in cancer therapy (2 papers), Cardiovascular Health and Disease Prevention (2 papers), Blood Pressure and Hypertension Studies (2 papers), Ethics in Clinical Research (1 paper), Genomics and Rare Diseases (1 paper) and Cardiac, Anesthesia and Surgical Outcomes (1 paper). The work is most often cited by research in Cancer Research (139 citations), Oncology (197 citations) and Pathology and Forensic Medicine (39 citations). Hannah Maynard has collaborated with scholars based in United States, Canada and Israel. Frequent co-authors include Eileen M. O’Reilly, David P. Kelsen, Talia Golan, Hedy L. Kindler, Maeve A. Lowery, Zsofia K. Stadler, Richard Kinh Gian, Amiel Segal, Alice P. Chen and Marinela Capanu. Their work appears in journals such as Journal of Clinical Oncology, Cancer and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.